 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. News Gilead Warned by Democrats Over "Quad" PricingAugust 17, 2012 Fourteen Democratic members of Congress have written Gilead Sciences to ask that the company reasonably price its yet-to-be-approved AIDS drug "Quad". The once-a-day first-line AIDS treatment, which contains four medications, was recommended for approval by a Food and Drug Administration advisory panel. The congressional representatives fear that Gilead may charge as much as $34,000 per patient per year for Quad, which could further strain state AIDS funding programs.  Visit the CDC's website to find out more about their activities, publications and services.
Comment by: Anonymous
Fri., Aug. 24, 2012 at 10:52 am EDT Anyone bother to look at what they pay the CEO and other top end people?
Comment by: michael
(los angeles)
Fri., Aug. 24, 2012 at 3:02 am EDT rather silly that "the" government is begging these scumbags to price the drugs reasonably (below 34k) when it is their funding paying for it to begin with. here's an idea, get rid of patents on life saving medicine and allow generics to enter the market...... sickening.....
Comment by: John-Manuel Andriote
(Norwich, CT)
Thu., Aug. 23, 2012 at 5:30 pm EDT It' s obscene--and makes no medical, moral or economic sense--to charge such an outrageously inflated price for medicaiton that costs pennies to produce, especially when it means further burdening the federal and state programs that pay for HIV medications with taxpayer dollars. Big Pharma needs to get a clue that Americans aren't going to keep accepting the 'unspoken bargain' in which we are forced to pay more for prescription drugs than any other people in the world--after our tax dollars already pay for their research and development costs!
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|
Email
Comments
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
